BioHarvest Sciences Inc. Common Stock
BHSTNASDAQBasic Materials● Active
$3.19
$-0.06(-1.85%)
Market Cap$55275363
P/E Ratio—
52W High$12.8
52W Low$3.0602
BioHarvest Sciences Inc. Common Stock (BHST) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BHST · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.11
Est. -$0.13 · +15.4%
Revenue
$0.01B
Est. $0.01B · +0.1%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▲ Beat EPS✓ 3-Quarter EPS Beat Streak
BHST reports quarterly as a NASDAQ-listed Agricultural Inputs company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.13 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 14, 2026 | -$0.13 | -$0.11 | +15.4% | $0.01B | $0.01B | +0.1% |
| ▲ Q1 FY2026 | Mar 31, 2026 | -$0.10 | -$0.10 | +4.8% | $0.01B | $0.01B | -1.5% |
| — Q4 FY2025 | Nov 13, 2025 | -$0.14 | -$0.14 | +0.0% | $0.01B | $0.01B | -1.0% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -$0.11 | -$0.15 | -36.4% | $0.01B | $0.01B | -6.0% |
| ▲ Q2 FY2025 | May 15, 2025 | -$0.15 | -$0.13 | +13.3% | $0.01B | $0.01B | -8.2% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -$0.12 | -$0.17 | -41.7% | $0.01B | $0.01B | +0.6% |
| ▼ Q4 FY2024 | Nov 25, 2024 | -$0.05 | -$0.16 | -220.0% | $0.01B | $0.01B | -9.7% |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.13
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Beat
EPS Actual
-$0.11
EPS Est.
-$0.13
EPS Surpr.
+15.4%
Revenue
$0.01B
Q1 FY2026
Mar 31, 2026Beat
EPS Actual
-$0.10
EPS Est.
-$0.10
EPS Surpr.
+4.8%
Revenue
$0.01B
Q4 FY2025
Nov 13, 2025
EPS Actual
-$0.14
EPS Est.
-$0.14
EPS Surpr.
+0.0%
Revenue
$0.01B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
-$0.15
EPS Est.
-$0.11
EPS Surpr.
-36.4%
Revenue
$0.01B
Q2 FY2025
May 15, 2025Beat
EPS Actual
-$0.13
EPS Est.
-$0.15
EPS Surpr.
+13.3%
Revenue
$0.01B
Q1 FY2025
Mar 31, 2025Miss
EPS Actual
-$0.17
EPS Est.
-$0.12
EPS Surpr.
-41.7%
Revenue
$0.01B
Q4 FY2024
Nov 25, 2024Miss
EPS Actual
-$0.16
EPS Est.
-$0.05
EPS Surpr.
-220.0%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.18 | $0.20 | $0.22 | 1 |
| Q3 FY2028 | $0.24 | $0.26 | $0.29 | 1 |
| Q2 FY2028 | $0.12 | $0.13 | $0.14 | 1 |
| Q1 FY2028 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Q4 FY2027 | $0.04 | $0.04 | $0.05 | 1 |
| Q3 FY2027 | $-0.04 | $-0.04 | $-0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 14, 2026 | +15.4% | $4.01 | $4.16 | +3.74% |
| ▲ Q1 FY2026 | Mar 31, 2026 | +4.8% | $4.27 | $4.34 | +1.64% |
| ▲ Q4 FY2025 | Nov 13, 2025 | +0.0% | $7.90 | $7.30 | -7.59% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -36.4% | $8.76 | $8.82 | +0.68% |
| ▲ Q2 FY2025 | May 15, 2025 | +13.3% | $6.60 | $6.43 | -2.58% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -41.7% | $6.56 | $6.19 | -5.64% |
| ▼ Q4 FY2024 | Nov 25, 2024 | -220.0% | $6.22 | $6.30 | +1.29% |
| ▲ Q4 FY2024 | Oct 23, 2024 | +58.0% | $4.80 | $4.80 | +0.00% |
Q2 FY2026+3.74%
Report Date
May 14, 2026
EPS Beat/Miss
+15.4%
Price Before
$4.01
Price After
$4.16
Q1 FY2026+1.64%
Report Date
Mar 31, 2026
EPS Beat/Miss
+4.8%
Price Before
$4.27
Price After
$4.34
Q4 FY2025-7.59%
Report Date
Nov 13, 2025
EPS Beat/Miss
+0.0%
Price Before
$7.90
Price After
$7.30
Q3 FY2025+0.68%
Report Date
Aug 11, 2025
EPS Beat/Miss
-36.4%
Price Before
$8.76
Price After
$8.82
Q2 FY2025-2.58%
Report Date
May 15, 2025
EPS Beat/Miss
+13.3%
Price Before
$6.60
Price After
$6.43
Q1 FY2025-5.64%
Report Date
Mar 31, 2025
EPS Beat/Miss
-41.7%
Price Before
$6.56
Price After
$6.19
Q4 FY2024+1.29%
Report Date
Nov 25, 2024
EPS Beat/Miss
-220.0%
Price Before
$6.22
Price After
$6.30
Q4 FY2024+0.00%
Report Date
Oct 23, 2024
EPS Beat/Miss
+58.0%
Price Before
$4.80
Price After
$4.80
Avg Beat Reaction-0.96%
Avg Miss Reaction-1.22%
Beat Rate5 / 8 quarters
Largest Move-7.59% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BHST ends December
BioHarvest Sciences Inc. Common Stock (BHST) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.11 — beating the analyst consensus of $-0.13 by +15.4%. BHST has beaten EPS estimates for 3 consecutive quarters. The next BHST earnings date is expected around September 1, 2026.
Each quarter, investors track BHST earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BHST revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BHST's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BHST earnings · 5 questionsBioHarvest Sciences Inc. Common Stock's next earnings report is expected around September 1, 2026. BHST typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BHST historically reports after market close (AMC).
BHST earnings datewhen is BHST earningsBHST next earnings datewhen does BHST report earningsBHST earnings calendar
▸ Source: FMP · BioHarvest Sciences Inc. Common Stock SEC filings · US GAAP · BioHarvest Sciences Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026